USTC achieves thousand-kilometer quantum key distribution
2023-06-13
(Press-News.org) A point-to-point long-distance quantum key distribution (QKD) over a distance of 1,002 km has been achieved by scientists from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences (CAS), and their collaborators from Tsinghua University, Jinan Institute of Quantum Technology, and Shanghai Institute of Microsystem and Information Technology (SIMIT), CAS. This milestone not only sets a new world record for non-relay QKD but also provides a solution for high-speed intercity quantum communication. The result was published in Physical Review Letters on May 25th.
QKD is based on the principles of quantum mechanics and enables secure key distribution between two remote parties. When combined with the "one-time pad" encryption method, it can achieve the highest level of security for confidential communication. However, the distance of QKD has been limited by factors such as the channel loss and system noise.
The twin-field QKD (TF-QKD) using sending-or-not-sending (SNS) protocol was demonstrated in the experiment, improving the relation between the key rate and channel transmittance from a linear η to its square root η. Therefore, it can achieve a much longer secure distance than traditional QKD protocols.
To achieve long-distance QKD, the research team collaborated with Yangtze Optical Fibre and Cable Joint Stock Limited Company (YOFC) and used ultra-low-loss fiber based on pure silica core technology, which achieved a maximum attenuation of 0.16 dB/km. SIMIT developed ultra-low-noise superconducting single-photon detectors. By implementing multiple filters at temperatures of 40 K and 2.2 K to suppress dark counts caused by thermal radiation, the noise of the single-photon detectors was reduced to around 0.02 cps. Furthermore, the team also developed a dual-band phase estimation scheme to avoid the spontaneous Raman scattering noise, reducing the system noise to below 0.01 Hz.
Based on the aforementioned technological developments, the team achieved TF-QKD over a record distance of 1002 km, with a key rate of 0.0034 bps. This work not only verifies the feasibility of the SNS-TF-QKD scheme at extremely long distances but also demonstrates that this protocol can achieve high key rates in many practical scenarios.
The success of this study holds significant implications for the advancement of secure quantum communication. It opens up new possibilities for long-distance quantum key distribution and paves the way for the realization of high-speed intercity quantum communication networks.
Paper link：https://journals.aps.org/prl/abstract/10.1103/PhysRevLett.130.210801
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-06-13
Posters
All poster presentations will take place on Monday, June 12, 2023, from 12:15 to 1:30 p.m. EDT, or Tuesday, June 13, 2023, from 12:15 to 1:30 p.m. EDT at the Baltimore Convention Center, Exhibit Hall E, Level 100.
Abstract 4-M (Monday)
Avoiding Clinical Inertia: Comparing Time to Intensification of Glucagon-like
peptide-1 (GLP-1) Receptor Agonists in Patients with Type 2 Diabetes Mellitus Among Clinical Pharmacists versus Providers
Clinical pharmacists have a significant impact on medication optimization and reduction ...
2023-06-13
Niigata, Japan - The Department of Neurology at Niigata University has developed a new in silico method for evaluating the pathogenicity of missense variants using AlphaFold2 (MOVA). Rare variants in the causative gene of ALS are present in 10-30% of sporadic ALS cases, which highlights the need for accurate and efficient pathogenicity prediction methods. To predict the pathogenicity of the variants, in silico analysis methods are commonly used. In some ALS causal genes, the mutations are concentrated in specific regions, and the accuracy of pathogenicity prediction can be improved by considering the positional information of the variants. ...
2023-06-13
Niigata, Japan - The gold standard test for predicting the onset of diabetic kidney disease is albuminuria. However, detecting albuminuria alone has limited sensitivity and specificity in end-stage renal failure with a decreased estimated glomerular filtration rate. This is supported by several reports, which state that about half of the type 2 diabetes patients who developed kidney dysfunction showed no preceding albuminuria.
In this study, the authors propose the possibility of diagnosing tubular abnormalities in diabetic kidney disease at an early stage and connecting them to treatment by combining the evaluation of sodium concentration using 23Na MRI ...
2023-06-13
Older female mice had more immune cells entering areas of the body where they shouldn’t according to a new study, demonstrating that sex differences contribute to age-related inflammation that needs to be considered in future research.
In a paper published in Journal of Leukocyte Biology today (Tuesday 13 June), at team of researchers led by Dr Myriam Chimen from the University of Birmingham have found that age significantly increases the number of immune cells entering the sack that holds major organs (peritoneal cavity) in female mice, when compared to young mice or older male mice.
The findings support previous studies that suggest ...
2023-06-13
Peer-reviewed / Randomised Controlled Trial / People
Study of healthy US adults found that a single dose of the VLA1553 vaccine candidate was generally safe, well tolerated and provokes an immune response.
After a single vaccination, the vaccine produced neutralizing antibody levels which are thought to protect against chikungunya disease in 99% (263/266) of participants.
Antibody levels declined 28 days after vaccination, but seroprotection persisted in more than 96% (233/242) participants after six months.
Most adverse events were moderate or mild and the authors say its safety profile is similar to other licensed vaccines
The VLA1553 vaccine candidate ...
2023-06-13
Glasgow, UK: The informed consent process in biomedical research is biased towards people who can meet with clinical study staff during the working day. For those who have the availability to have a consent conversation, the time burden can be off-putting. Professor Eric Vilain, from the Department of Paediatrics, University of California, Irvine, USA, will tell the European Society of Human Genetics annual conference today (Tuesday 13 June) how results from his team’s study of the use of a chatbot (GIA – ‘Genetics Information Assistant’ ...
2023-06-13
Weight and body mass index (BMI) policies introduced by NHS commissioning groups in England are inappropriate and worsening health inequalities, according to a new study published in BMC Medicine today [13 June] that analysed nearly 490,000 hip surgeries. With one in ten people likely to need a joint replacement in their lifetime, many thousands of patients are directly affected by these policies.
Rules implemented by NHS clinical commissioning groups (CCGs) across England to change the access to hip and knee replacement surgery for patients who are overweight or obese have been in effect for over ten years. ...
2023-06-13
In a world of continuously warmer temperatures, a growing consensus demands that energy sources have zero, or next-to-zero, carbon emissions. That means growing beyond coal, oil, and natural gas by getting more energy from renewable sources.
One of the most promising renewable energy carriers is clean hydrogen, which is produced without fossil fuels.
It’s a promising idea because the most abundant element in the universe is hydrogen, found in 75 percent of all matter. Moreover, a hydrogen molecule has two paired atoms—Gemini twins that are both non-toxic and highly combustible.
Hydrogen’s combustive potential ...
2023-06-13
A decade after UC San Francisco scientists identified an over-the-counter antihistamine as a treatment for multiple sclerosis, researchers have developed an approach to measure the drug’s effectiveness in repairing the brain, making it possible to also assess future therapies for the devastating disorder.
The researchers, led by physician-scientist Ari Green, MD, who together with neuroscientist Jonah Chan, PhD, first identified clemastine as a potential MS therapy, used MRI scans to study the drug’s impact on the brain of 50 participants in a clinical study.
In MS, patients lose myelin, the protective insulation around ...
2023-06-13
As adoption of Continuous Glucose Monitoring (CGM) continues to increase, there is a growing body of evidence supporting the use of this technology in improving diabetes outcomes for patients with Type 1 or Type 2 Diabetes. A new supplement in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) provides an excellent perspective of the past, present, and future of CGM. Click here to read the supplement now.
In the supplement Rickson et al. review the rapid pace in which diabetes technology has progressed and the implications for relying on rigorous and extensive timelines to publish randomized controlled trials to impact ...
LAST 30 PRESS RELEASES:
[Press-News.org] USTC achieves thousand-kilometer quantum key distribution
